Editorial Comment from Dr Sazuka to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan
- PMID: 34013556
- DOI: 10.1111/iju.14597
Editorial Comment from Dr Sazuka to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan
Comment on
-
Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.Int J Urol. 2021 Aug;28(8):814-819. doi: 10.1111/iju.14583. Epub 2021 May 19. Int J Urol. 2021. PMID: 34013614
References
-
- Soave A, Riethdorf S, Dahlem R et al. A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy. Int. J. Cancer 2017; 140: 381-9.
-
- Baard J, de Bruin DM, Zondervan PJ, Kamphuis G, de la Rosette J, Laguna MP. Diagnostic dilemmas in patients with upper tract urothelial carcinoma. Nat. Rev. Urol. 2017; 14: 181-91.
-
- Shiga M, Nagumo Y, Chihara I et al. Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: analysis of the Hospital-Based Cancer Registry data in Japan. Int. J. Urol. 2021; 28: 814-9.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
